Evidence map›Paper›PMID 37498422›Full record

Trial reportInternational urology and nephrology2023

Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study.

Halil Lutfi Canat, Cenk Gurbuz, Muammer Bozkurt

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International urology and nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06564415 (European Registry for Transperineal Laser Ablation of Prostate), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06564415 recruitingnot on this mapstarted 2024, after this paper: background citation

European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Obstruction (BPO)

Typeobservational_patient_registrySponsorUniversity of FlorenceRan2024 to 2034Enrolled2,500ConditionsBenign Prostatic Hyperplasia, Prostatic DiseasesArmsTransperineal Laser Ablation of Prostate
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Halil Lutfi CanatDepartment of Urology, Basaksehir Cam and Sakura City Hospital, Basaksehir Olimpiyat Bulvarı yolu, Basaksehir, 34480, Istanbul, Turkey.
Cenk GurbuzDepartment of Urology, Osmanoglu Hospital, Istanbul, Turkey.
Muammer BozkurtDepartment of Urology, Basaksehir Cam and Sakura City Hospital, Basaksehir Olimpiyat Bulvarı yolu, Basaksehir, 34480, Istanbul, Turkey. mdmbozkurt@gmail.com.ORCID http://orcid.org/0000-0001-9011-7293
Eskişehir City Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to compare the first-year results of Transurethral resection of the prostate (TURP), the gold standard method, and Transperineal laser ablation (TPLA) techniques. MATERIAL AND

methodsThis study was designed as a prospective, randomized, controlled, and single-center and was conducted between November 2021 and February 2023. TURP candidates were included in the study. Demographic data and perioperative data were recorded. Preoperative and first-year International Prostate Symptom Score (IPSS), International Erectile Function Index (IIEF-5), Male Sexual Health Questionnaire-Ejaculatory Dysfunction (MSHQ-EjD), QoL, peak urinary flow rate (Q

resultsFifty patients were included in the study and were assigned to equal numbers of groups. TPLA group had a higher ASA score (p = 0.03). There was improvement in IPSS, Q

conclusionAccording to the first-year results of TPLA, the symptomatic improvement effect without sacrificing ejaculatory functions is comparable to TURP. We think that this method will can be an alternative, especially for patients who want to avoid ejaculatory dysfunction, who have a high risk of anesthesia, and whose anticoagulant/antiplatelet therapy cannot be discontinued.

Indexed as

Laser TherapyProstatic HyperplasiaTransurethral Resection of ProstateHumansMaleProspective StudiesProstateQuality of LifeTreatment OutcomeBenign prostatic hyperplasiaTransperineal laser ablationTransurethral resection of the prostate

Identifiers

PMID37498422
OpenAlexW4385295220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.